Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AZD3293
AZD3293
Lilly and AstraZeneca Receive FDA Fast Track Designation for AZD3293, an Investigational Treatment for Early Alzheimer's Disease
Yahoo
Mon, 08/22/16 - 11:36 am
Eli Lilly
AstraZeneca
AZD3293
fast track
FDA
Alzheimer's disease
AstraZeneca, Eli Lilly move closely watched BACE Alzheimer's trial into PhIII
Fierce Biotech
Fri, 04/8/16 - 10:59 am
AstraZeneca
Eli Lilly
BACE inhibitors
Alzheimer's disease
AZD3293
AstraZeneca and Lilly move Alzheimer's drug into big trial
Yahoo/Reuters
Mon, 12/1/14 - 07:39 am
AstraZeneca
Eli Lilly
Alzheimer's disease
AZD3293
LY3314814
Lilly to Pay AstraZeneca $500 Million in Alzheimer’s Push
Bloomberg
Tue, 09/16/14 - 09:21 am
Eli Lilly
AstraZeneca
Alzheimer's disease
BACE inhibitors
AZD3293
Can These 2 Health Care Giants Overcome Big Pharma's Alzheimer's Struggles?
Motley Fool
Mon, 02/17/14 - 03:24 pm
Alzheimer's disease
Merck
AstraZeneca
BACE inhibitors
MK-8931
AZD3293
AstraZeneca’s Alzheimer’s Drug Advances: Now What?
Motley Fool
Fri, 02/14/14 - 12:51 pm
AstraZeneca
Alzheimer's disease
AZD3293
AstraZeneca takes on Merck in Alzheimer's drug race
Yahoo/Reuters
Thu, 02/6/14 - 09:57 am
AstraZeneca
Merck
Alzheimer's disease
AZD3293
BACE inhibitors